secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIO-RAD LABORATORIES, INC. (BIO)
CIK:        0000012208
Form:       8-K
Filed at:   2023-02-23T23:59:59+00:00
Accession:  0000012208-23-000035
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Bio-Rad discloses Sartorius AG 2022 financials: sales €4.17B, net profit €913M
------------------------------------------------------------------------------

- Sartorius AG reported 2022 sales revenue of €4,174.7M and gross profit of €2,196.5M.
- EBIT of €1,064.8M and net profit of €913.1M for the year ended December 31, 2022.
- Cash flow from operations €734.2M; investing activities used €1,129.9M.
- Total equity at year-end €2,658.9M; current assets €2,023.2M, current liabilities €1,803.4M.
- Data sourced from Sartorius's IFRS consolidated financial statements publicly disclosed on Feb 17, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/12208/000001220823000035/0000012208-23-000035-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/12208/000001220823000035/bio-20230223.htm
  HTML page:      https://secwatch.observer/filing/0000012208-23-000035

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer